Literature DB >> 30981586

Sex-dependent changes in ketamine-induced locomotor activity and ketamine pharmacokinetics in preweanling, adolescent, and adult rats.

Sanders A McDougall1, Ginny I Park2, Goretti I Ramirez2, Vanessa Gomez2, Brittnee C Adame2, Cynthia A Crawford2.   

Abstract

Although ketamine has long been known to increase locomotor activity, only recently was it realized that this behavioral effect varies according to both sex and age. The purpose of the present study was threefold: first, to measure the locomotor activating effects of ketamine in male and female rats across early ontogeny and into adulthood; second, to assess ketamine and norketamine pharmacokinetics in the dorsal striatum and hippocampus of the same age groups; and, third, to use curvilinear regression to determine the relationship between locomotor activity and dorsal striatal concentrations of ketamine and norketamine. A high dose of ketamine (80 mg/kg, i.p.) was administered in order to examine the complete cycle of locomotor responsiveness across a 280-min testing session. In separate groups of rats, the dorsal striata and hippocampi were removed at 10 time points (0-360 min) after ketamine administration and samples were assayed for ketamine, norketamine, and dopamine using HPLC. In female rats, ketamine produced high levels of locomotor activity that varied only slightly among age groups. Male preweanling rats responded like females, but adolescent and adult male rats exhibited lesser amounts of ketamine-induced locomotor activity. Ketamine and norketamine pharmacokinetics, especially peak values and area under the curve, generally mirrored age- and sex-dependent differences in locomotor activity. Among male rats and younger female rats, dorsal striatal ketamine and norketamine levels accounted for a large proportion of the variance in locomotor activity. In adult female rats, however, an additional factor, perhaps involving other ketamine and norketamine metabolites, was influencing locomotor activity.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Ketamine; Locomotor activity; Ontogeny; Pharmacokinetics

Year:  2019        PMID: 30981586      PMCID: PMC7059997          DOI: 10.1016/j.euroneuro.2019.03.013

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  65 in total

1.  Sex Differences in the Pharmacokinetics of Low-dose Ketamine in Plasma and Brain of Male and Female Rats.

Authors:  Samantha K Saland; Mohamed Kabbaj
Journal:  J Pharmacol Exp Ther       Date:  2018-09-13       Impact factor: 4.030

2.  The ontogeny of excitatory amino acid receptors in rat forebrain--I. N-methyl-D-aspartate and quisqualate receptors.

Authors:  T R Insel; L P Miller; R E Gelhard
Journal:  Neuroscience       Date:  1990       Impact factor: 3.590

3.  Sexual dimorphism in phencyclidine in vitro metabolism and pharmacokinetics in rats.

Authors:  S R Shelnutt; M Gunnell; S M Owens
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

Review 4.  Ovarian steroids and selective estrogen receptor modulators activity on rat brain NMDA and AMPA receptors.

Authors:  M Cyr; O Ghribi; C Thibault; M Morissette; M Landry; T Di Paolo
Journal:  Brain Res Brain Res Rev       Date:  2001-11

5.  Ketamine anaesthesia has no effect on striatal dopamine metabolism in rats.

Authors:  N Koshikawa; K Tomiyama; K Omiya; M Kobayashi
Journal:  Brain Res       Date:  1988-03-22       Impact factor: 3.252

6.  Chronic ketamine administration modulates midbrain dopamine system in mice.

Authors:  Sijie Tan; Wai Ping Lam; Maria S M Wai; Wan-Hua Amy Yu; David T Yew
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

7.  Effects of ketamine on brain monoamine levels in rats.

Authors:  H P Kari; P P Davidson; H H Kohl; M M Kochhar
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1978-06

8.  Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression.

Authors:  Marije aan het Rot; Katherine A Collins; James W Murrough; Andrew M Perez; David L Reich; Dennis S Charney; Sanjay J Mathew
Journal:  Biol Psychiatry       Date:  2010-01-15       Impact factor: 13.382

9.  Sexual dimorphic effects of chronic phencyclidine in rats.

Authors:  W D Wessinger
Journal:  Eur J Pharmacol       Date:  1995-04-13       Impact factor: 4.432

10.  Physiological, pharmacokinetic and liver metabolism comparisons between 3-, 6-, 12- and 18-month-old male Sprague Dawley rats under ketamine-xylazine anesthesia.

Authors:  Marie-Chantal Giroux; Raphael Santamaria; Pierre Hélie; Patrick Burns; Francis Beaudry; Pascal Vachon
Journal:  Exp Anim       Date:  2015-10-21
View more
  8 in total

1.  Preclinical toxicological study of prolonged exposure to ketamine as an antidepressant.

Authors:  Julia Zaccarelli-Magalhães; André Rinaldi Fukushima; Natalia Moreira; Marianna Manes; Gabriel Ramos de Abreu; Esther Lopes Ricci; Paula A Faria Waziry; Helenice de Souza Spinosa
Journal:  Pharmacol Rep       Date:  2019-12-20       Impact factor: 3.024

2.  MK801-induced locomotor activity in preweanling and adolescent male and female rats: role of the dopamine and serotonin systems.

Authors:  Sanders A McDougall; Matthew G Apodaca; Ginny I Park; Angie Teran; Timothy J Baum; Nazaret R Montejano
Journal:  Psychopharmacology (Berl)       Date:  2020-05-22       Impact factor: 4.530

3.  Effects of monoamine depletion on the ketamine-induced locomotor activity of preweanling, adolescent, and adult rats: Sex and age differences.

Authors:  Cynthia A Crawford; Andrea E Moran; Timothy J Baum; Matthew G Apodaca; Nazaret R Montejano; Ginny I Park; Vanessa Gomez; Sanders A McDougall
Journal:  Behav Brain Res       Date:  2019-10-05       Impact factor: 3.332

4.  Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats.

Authors:  Helena M Abelaira; Thayse Rosa; Airam B de Moura; Natalia M Andrade; Nicoly S Martinello; Larissa R Maciel; Maria Eduarda M Botelho; Laura A Borba; Beatriz C Chede; Camila O Arent; Larissa Joaquim; Sandra Bonfante; Lucinéia G Danielski; Talita Tuon; Fabricia Petronilho; João Quevedo; Gislaine Z Réus
Journal:  Mol Neurobiol       Date:  2022-01-07       Impact factor: 5.590

5.  Effects of repeated treatment with the 5-HT1A and 5-HT1B agonists (R)-( +)-8-hydroxy-DPAT and CP-94253 on the locomotor activity and axillary temperatures of preweanling rats: evidence of tolerance and behavioral sensitization.

Authors:  Sanders A McDougall; Jordan A Taylor; Matthew J Roe; Constance J Greenwood
Journal:  Psychopharmacology (Berl)       Date:  2021-11-24       Impact factor: 4.530

6.  Effects of dopamine and serotonin synthesis inhibitors on the ketamine-, d-amphetamine-, and cocaine-induced locomotor activity of preweanling and adolescent rats: sex differences.

Authors:  Sanders A McDougall; Jasmine W Rios; Matthew G Apodaca; Ginny I Park; Nazaret R Montejano; Jordan A Taylor; Andrea E Moran; Jasmine A M Robinson; Timothy J Baum; Angie Teran; Cynthia A Crawford
Journal:  Behav Brain Res       Date:  2019-10-23       Impact factor: 3.332

7.  Sex- and stress-dependent effects of a single injection of ketamine on open field and forced swim behavior.

Authors:  Paul J Fitzgerald; Savannah K Kounelis-Wuillaume; Ali Gheidi; Jonathan D Morrow; Joanna L Spencer-Segal; Brendon O Watson
Journal:  Stress       Date:  2021-02-01       Impact factor: 3.493

8.  Gestational hypoxia in late pregnancy differentially programs subcortical brain maturation in male and female rat offspring.

Authors:  E Nicole Wilson; Steve Mabry; Jessica L Bradshaw; Jennifer J Gardner; Nataliya Rybalchenko; Rachel Engelland; Oluwadarasimi Fadeyibi; Oluwatobiloba Osikoya; Spencer C Cushen; Styliani Goulopoulou; Rebecca L Cunningham
Journal:  Biol Sex Differ       Date:  2022-09-30       Impact factor: 8.811

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.